EUVIMEDEUVIMED entdecken
Crossref

Nuclear Factor Erythroid 2-Related Factor 2 Activator DDO-1039 Ameliorates Podocyte Injury in Diabetic Kidney Disease via Suppressing Oxidative Stress, Inflammation, and Ferroptosis

Xing Liu iD, Xiuwen Zhai, Xiaoyu Wang, Xiaodong Zhu, Ziyue Wang, Zhengyu Jiang, Hao Bao, ZhaoHong Chen

Antioxidants & Redox Signaling · 01.05.2025 · 42 (13-15) · 787-806

DOI: 10.1089/ars.2024.0653 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, erschienen am 01.05.2025. Verfasst von Xing Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China. Hauptthemen laut MEDLINE: Podocytes, Diabetic Nephropathies, Oxidative Stress, NF-E2-Related Factor 2. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 79 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PodocytesDiabetic NephropathiesOxidative StressNF-E2-Related Factor 2FerroptosisInflammationAnimalsMiceHumansDiabetes Mellitus, ExperimentalMaleDisease Models, Animal

Stichwörter der Autor:innen

Keap1-Nrf2 pathwayROSapoptosisdiabetic kidney diseaseferroptosisinflammationpodocyte

Substanzen

NF-E2-Related Factor 2

Autor:innen und Institutionen

  • National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
  • Clinical Research Center, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, China.
  • Nanjing University School of Medicine, Nanjing, China.
  • State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China.

ORCID-Profile: Xing Liu

Zitieren

APA

Liu, X., Zhai, X., Wang, X., Zhu, X., Wang, Z., Jiang, Z., Bao, H., & Chen, Z. (2025). Nuclear Factor Erythroid 2-Related Factor 2 Activator DDO-1039 Ameliorates Podocyte Injury in Diabetic Kidney Disease via Suppressing Oxidative Stress, Inflammation, and Ferroptosis. Antioxidants & Redox Signaling, 42(13-15), 787-806. https://doi.org/10.1089/ars.2024.0653

Vancouver

Liu X, Zhai X, Wang X, Zhu X, Wang Z, Jiang Z, et al. Nuclear Factor Erythroid 2-Related Factor 2 Activator DDO-1039 Ameliorates Podocyte Injury in Diabetic Kidney Disease via Suppressing Oxidative Stress, Inflammation, and Ferroptosis. Antioxidants & Redox Signaling. 2025;42(13-15):787-806. doi:10.1089/ars.2024.0653

BibTeX
@article{Liu2025,
  author = {Liu, Xing and Zhai, Xiuwen and Wang, Xiaoyu and Zhu, Xiaodong and Wang, Ziyue and Jiang, Zhengyu and Bao, Hao and Chen, ZhaoHong},
  title = {Nuclear Factor Erythroid 2-Related Factor 2 Activator DDO-1039 Ameliorates Podocyte Injury in Diabetic Kidney Disease via Suppressing Oxidative Stress, Inflammation, and Ferroptosis},
  journal = {Antioxidants & Redox Signaling},
  year = {2025},
  volume = {42},
  number = {13-15},
  pages = {787--806},
  doi = {10.1089/ars.2024.0653}
}
Kostenlos starten →